Nutriband Inc.(NASDAQ:NTRB) 
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The compa...
Website: https://nutriband.com
Founded: 2016
CEO: Gareth Sheridan
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.40
H 4.53
L 4.32
C 4.32
V 7,340
10EMA 4.32
20EMA 4.32
60EMA 4.32
120EMA 4.32
250EMA 4.32